Publications 2000
  1. Bouma G en Peña AS.
    Etiologie van chronische darmontstekingen
    .
    Meer oorzaken voor één klinisch beeld. Pharm Weekbl 2000, 135 (35):1288-1292.
  2. Franchimont D, Bouma G, Galon J, WolkersdÖrfer GW, Haidan A, Chrousos GP, and Bornstein SR.
    Adrenal Cortical Activation in Murine Colitis
    Gastroenterology 2000 119: 1560-1568.
     
  3. Corominas H, Domènech, Díaz M, González D, Roca M, García González MA, Peña AS, Baiget M.
    Allelic variants of the thiopurine S-methyltransferase (TPMT) deficiency in patients with ulcerative colitis and healthy controls.

    Amer J Gastroenterol
    2000; 95:2313-2317.
     
  4. Csizmadia CGDS, Mearin ML, Oren A, Kromhout A, Crusius JBA, von Blomberg BME, Peña AS, Wiggers MNL, Vandenbroucke JP.

    Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome.
    J Pediatr 2000;137(6):756-761.
     

  5. García-González MA, Crusius JBA, Strunk MHP, Bouma G, Pérez-Centeno CM, Pals G, Meuwissen SGM, Peña AS.
    TGFB1
    gene polymorphisms and  inflammatory bowel disease.
    Immunogenetics 2000;51(10): 869-872.
     
  6. Killestein J, Schrijver HMJ, Crusius JBA, Pérez C, Uitdehaag BMJ, Peña AS, Polman CH.
    Intracellular adhesion molecule-1 polymorphisms and genetic susceptibility to multiple sclerosis: Additional data and meta-analysis.

    Annals of Neurology 2000; 47(2): 277-279.
     
  7. Laine ML, Farré MA, Crusius JBA, van Winkelhoff AJ, Peña AS.
    The Mouthwash: A non-invasive sampling method to study cytokine gene polymorphisms.
    J. Periodontol 2000;71:1315-1318.
  8. Nemetz A, Peña AS.

    Genetic factors and osteoporotic fractures in elderly people. Study supports possibility of differences in development of osteoporotic fractures between sexes.

    BMJ 2000;320(7250):1670; author reply -1

     
  9. Molnar T, Tiszlavicz L, Balogh A, Guylai C, Nagy F, Peña AS, Lonovics J.
    Crohn's disease of the bladder - a new type of metastatic granulomatous inflammatory disease?

    Am J Gastroenterol 2000;95(3): 850-851.

  10. Peña AS.
    Genetic factors determining the host response to Helicobacter pylori.

    World J Gastroenterol 2000
    ;6(5): 624-625. 
  11. Peña AS en Bouma G.
    Corticosteroïden bij chronische darmontstekingen. Lokale versus systemische toediening.

    Pharm Weekbl 2000
    , 135 (35):1309-1313.
  12. Plummer M, Vivas J, Fauchère J-L, Del Giudice G, Peña AS, Ponzetto A, Lopez G, Miki K, Oliver W, Muñoz N.
    Helicobacter pylori
    and stomach Cancer: A case control study in Venezuela.

    Cancer Epidemiol Biomarkers Prev 2000;9:961-965.
     

  13. Van de Wal Y, Kooy Y, Van Veelen P, Vader W, Peña AS, Koning F.
    Coeliac Disease: it takes three to tango!
    Gut
    2000;46:734-737
     
  14. Wahab PJ, Crusius JBA, Meijer JWR, Uil JJ, Mulder CJJ.
    Cyclosporin in the treatment of adults with refractory coeliac disease- an open pilot study
    .
    Aliment Pharmacol Ther
    2000; 14(6): 767-774.
     
  15. Peña AS, Manoliu RA, Bloemena E, Cohen A, Lobo A, Rutgeerts P, Sachar D.

    Case presentation: mild to moderate Crohn’s disease of the small and large bowel.

    Drugs of Today (Prous Science), 2000; 36 (Suppl. G): 103-107.

  16. Stange E, Cohen Z, Gomollón, Lobo A, Löfberg R, Peña AS, Rutgeerts P, Sachar D, Tremaine W.

    Case presentation: steroid refractory colitis..

    Drugs of Today (Prous Science), 2000; 36 (Suppl. G): 129-133.

  17. Peña AS. Can we select patients for specific immunomodulatory therapy?
    In: IBD, salicylates and other relevant therapies – 4. (Ed.: Jewell DP).
    Research and Clinical Forums, Wells Medical, 2000;22(2):177-184.

  18. Pérez-Pérez GI, Peña AS. Serology and the humoral, systemic and local immune response.
    In:Helicobacter pylori. Infection in gastroduodenal lesions. The second decade. (Eds.:Pajares García JM, Correa P, Pérez Pérez GI). Prous Science, 2000;67-75.